Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Validation of an industrial process to manufacture isosorbide bis(methyl carbonate) at pilot level

Descrizione del progetto

Un’alternativa ecologica per la produzione di polimeri

Il bisfenolo A (BPA), un monomero tossico derivato dal petrolio, è ampiamente utilizzato in ambito industriale per produrre polimeri utilizzabili come rivestimenti, adesivi e plastiche in policarbonato. Per superare le carenze associate a questo materiale, il progetto VIPRISCAR, finanziato dall’UE, mira a sviluppare e convalidare processi di produzione efficienti ricorrendo a una bioalternativa sicura al BPA nota come isosorbide bis(metilcarbonato) (IBMC). Come prova di principio, il progetto creerà anche diversi prototipi di IBMC da utilizzare nella produzione di rivestimenti industriali, adesivi e cateteri biomedici. L’uso di questa alternativa biologica nella produzione dei polimeri migliorerà la salute e la sicurezza ambientale dei prodotti polimerici.

Obiettivo

The use of isosorbide (IS), a still a low market volume bio-based chemical but with a high Cumulative Annual Growing Rate of 10.9%, in the manufacturing of intermediate building blocks and high volume polymers, such as polycarbonates, has some drawbacks that could be overcome by using isosorbide bis(methyl carbonate) (IBMC), a barely explored IS secondary building block which is proposed to enhance IS value chain. VIPRISCAR main objectives are: 1) To validate at pilot scale in an industrially relevant environment (TRL 5) a sustainable IBMC production process from IS; 2) To show a proof of principle for the added value IBMC brings to the market by demonstrating the usefulness of polymers derived thereof in three high-volume market sectors: industrial coatings, hot-melt adhesives, and biomedicine (antithrombotic-antimicrobial catheters).
Results expected are: 1) A validated highly-efficient IBMC production process (TRL 5) able to be up-scaled and produce, under suitable market conditions, IBMC at a similar price to that of current oil-based monomers used in polycarbonates and polyurethanes; 2) at least 1 IBMC-derived coating for automotive and furniture; 3) at least 1 IBMC-derived hot-melt adhesive; 4) 1 antithrombotic-antimicrobial IBMC-derived catheter. Exploitation encompasses patent licensing, collaborative research for further development to high TRLs and direct production-commercialization (industrial partners).
The 3-years project is divided in 4 phases consisting of 8 WPs: 1) IBMC manufacturing process improvement to move from the current TRL of 3 (TEC granted patent) to 4 (WP2); 2) IBMC up-scaling to TRL 5 (WP3); 3) Proof of principle of IBMC applications (WP4-Coatings, WP5-Adhesives, WP6-Catheters); 4) Horizontal issues: Management (WP1); techno-economic analysis, LCA, REACH, health-safety, barriers and standards (WP7); market analysis, business models-financial impacts, IPR and exploitation, risk management, communication and dissemination strategy (WP8).

Campo scientifico (EuroSciVoc)

Programma(i)

Argomento(i)

Meccanismo di finanziamento

BBI-RIA - Bio-based Industries Research and Innovation action

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) H2020-BBI-JTI-2017

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

FUNDACION TECNALIA RESEARCH & INNOVATION
Contributo netto dell'UE
€ 1 068 699,78
Indirizzo
PARQUE CIENTIFICO Y TECNOLOGICO DE GIPUZKOA MIKELETEGI PASEALEKUA 2
20009 DONOSTIA/SAN SEBASTIAN
Spagna
Regione
Noreste País Vasco Gipuzkoa
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 1 149 137,50

Partecipanti (9)